| Name | Title | Contact Details |
|---|---|---|
Michael Faas |
Chief Information Officer | Profile |
Hyosung America is the only manufacturer of ATMs and TCRs in North America. We inspire innovative recycling technology, branch transformation, and engineering innovation for the financial and retail industries. Established in 2007, our U.S. operations currently serve as one of the top two players in the U.S. financial institutions market. Our headquarters are located in Irving, Texas, and we have research and development software at our Global Software Center in Dayton, Ohio. Hyosung America is a subsidiary of South Korea, Hyosung Inc., a technology leader of self-service solutions in hardware, software, and banking services with over 30 years of experience in the industry.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.
Vangent is one of the leading companies in the Computers and Electronics sector.
IT Solutions Consulting, Inc. is one of the leading companies in the Computers and Electronics sector.
Options is a global leader in financial technology managed services and IT infrastructure products. We enable our clients to deliver a dual mandate: operating world-class financial technology infrastructure today, while supporting business scalability and new technology for tomorrow. Founded in 1993, the company began life as a hedge fund technology services provider. More than a decade ago, the company made a strategic decision to become the first provider to offer cloud services to the financial sector. Over 200 firms globally now leverage the Options platform, including the leading global investment banks, hedge funds, funds of funds, proprietary trading firms, private equity houses and exchanges. Options` global client presence currently spans over 20 countries worldwide with seven offices covering these regions. We have a global team and global infrastructure, allowing our customers with global operations to work with one single vendor. The feature-rich global platform, built to exacting investment bank standards, is further bolstered by industry-leading transparency around our pricing, a 24×7, high touch support model and unrivalled account management and customer engagement.